Latest CSL Behring Stories
Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and
DUBLIN, July 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hjmbvk/latestage) has announced the addition of the "Late-Stage Four-FCritical
Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa., June 24, 2014 /PRNewswire/ --
Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Dr.
Eligible Participants to Receive Payment Assistance with Out-of-Pocket Costs Associated with Hizentra® Therapy in the United States KING OF PRUSSIA, Pa., May 20, 2014 /PRNewswire/
Third annual awareness day shines a light on rare, potentially life-threatening condition KING OF PRUSSIA, Pa., May 14, 2014 /PRNewswire/ -- As a Diamond Sponsor of HAE Day on May 16, 2014,
Data showing improved pharmacokinetic profile to be presented at World Federation of Hemophilia Congress MELBOURNE, Australia, May 11, 2014 /PRNewswire/ -- Interim Phase II/III and
-- Leading-edge science at the core of $250 million expansion to drive long-term growth in promising bleeding disorders portfolio KING OF PRUSSIA, Pa., May 9, 2014 /PRNewswire/
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
KING OF PRUSSIA, Pa., May 2, 2014 /PRNewswire/ -- CSL Behring today announced that the first patient has been enrolled
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.